Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Check out some of our latest original content that was created and distributed as part of our ongoing collaborations with IR firms and other companies.

Safe Pro Group Inc. (NASDAQ: SPAI) Is ‘One to Watch’

Posted on July 9, 2025 by MissionIR
  • Unique, battle-tested and patented AI image analysis technology ready for commercialization in U.S. defense and public safety markets following more than two years of real-world usage in Ukraine.
  • Well positioned to capitalize on U.S. military’s increased strategic focus on domestically produced drone and AI technologies through integration with currently deployed platforms such as the U.S. Army’s Tactical Assault Kit (“TAK”) ecosystem for military force protection.
  • The patented SpotlightAI(TM) platform enables real-time detection of over 150 types of mines and UXO using AI and drone imagery and is now operating at scale, creating the world’s largest datasets of real-world landmines and UXO built on more than 1.6 million battlefield images processed and 28,000 threats identified.
  • Safe Pro is addressing a global, multi-billion-dollar need for scalable defense, public safety and demining solutions.

Safe Pro Group (NASDAQ: SPAI) is a mission-driven technology company delivering advanced AI-powered security and defense solutions. It is focused on serving customers in the defense, homeland security, humanitarian, law enforcement, and commercial markets where its AI, drone-based services and ballistic protective gear can synergistically deliver safety and operational efficiency.

At the heart of Safe Pro’s mission is its patented artificial intelligence (“AI”), machine learning (“ML”), deep learning and applied computer vision software technology. These tools are currently being used to rapidly detect small objects in drone-based video and imagery such as landmines and unexploded ordnance (“UXO”), enabling safer and more efficient field operations across global conflict and post-conflict zones and supporting efforts to improve the reliability of critical infrastructure. The company’s vision is to lead the evolution of security and threat detection through AI innovation, while its mission is to empower governments, enterprises, and humanitarian organizations with tools to respond to evolving threats at scale.

With a team of leaders and subject matter experts drawn from the defense, technology, and public safety sectors, Safe Pro Group delivers U.S.-developed next-generation AI and drone services through its Safe Pro AI and Airborne Response units and high-performance, American-made ballistic protective solutions through its Safe-Pro USA subsidiary.

The company is headquartered in Aventura, Florida.

Products

Safe Pro Group’s three business units operate across software, hardware, and field services to deliver a comprehensive suite of solutions. Each division plays a distinct role in supporting defense, humanitarian and public safety missions around the world.

Safe Pro AI

Safe Pro AI’s core AI-powered computer vision technology enables the rapid analysis of drone-based imagery to autonomously detect objects of interest. Its flagship product, SpotlightAI(TM) can detect and label over 150 types of explosive threats including landmines, cluster munitions, and unexploded ordnance (“UXO”). Built on more than two years of real-world usage in Ukraine and now including additional imagery being gathered from the Asian-Pacific region and Africa, SpotlightAI(TM) rapidly processes and creates high-resolution maps supported by the hyper scalability of the Amazon Web Services (“AWS”) cloud or detects threats in real-time locally through its OnSite Windows-based software application. Today, the platform boasts one of the world’s largest datasets built on over 1.6 million real-world battlefield images from Ukraine, identifying 28,000+ threats across more than 6,750 hectares, an area equivalent in size to Manhattan.

Airborne Response

Airborne Response is a leading provider of mission critical drone services using U.S. Government-compliant small uncrewed aircraft systems (“sUAS”) (drones). It serves enterprises in utilities and telecom and insurance with a full-range of drone-based critical infrastructure inspection and monitoring solutions as well as Drone-as-a-First Responder (“DFR”) services for law enforcement and public safety. It provides customers with actionable intelligence though data capture, analytics and processing powered by AI.

Safe-Pro USA

Safe-Pro USA manufactures ultra-premium, American-made ballistic protection systems including advanced body armor and ballistic plates as well as complete Explosive Ordnance Disposal (“EOD”) suits, demining aprons, and bomb blankets. All products exceed U.S. and NATO standards and are designed, engineered, and produced in the U.S., supporting customers across military, humanitarian, and law enforcement sectors.

Market Opportunity

Harnessing its patented, real-time, AI-powered processing of drone-based imagery, Safe Pro is creating a uniquely powerful ‘Next-Gen’ approach to situational awareness supporting ground-based personnel in safely completing their defense/military, humanitarian, law enforcement & commercial missions.

The global threat posed by landmines and UXO spans nearly 60 countries, affecting millions of civilians and imposing significant economic burdens, particularly in agriculture and infrastructure. In Ukraine alone, the contamination of 17 million hectares has resulted in $50+ billion in agricultural losses, with World Bank estimates projecting $30 billion needed in demining costs. According to the Landmine Monitor 2024, regions in Asia, Africa, and Latin America continue to report high casualty rates.

Safe Pro is positioned to capture a portion of the $15 billion+ global defense tech market, especially in AI-driven battlefield intelligence, drone surveillance, and threat detection. As a U.S.-based AI and defense technology provider with a HUBZone-certified manufacturing arm, Safe Pro is eligible for federal and state procurement programs, public safety grants, and critical infrastructure contracts, as well as global humanitarian demining efforts.

Leadership Team

Dan Erdberg, Chairman and CEO, brings over 20 years of experience as a C-level technology executive. He has led multiple Nasdaq listings in the drone, 5G, and satellite communications sectors, raised over $50 million in growth capital, and spearheaded Safe Pro Group’s corporate strategy and acquisitions.

Theresa Carlise, Chief Financial Officer, has more than 30 years of experience in financial leadership roles for public companies. Her expertise includes equity transactions, strategic planning, and financial restructuring. She served as Chief Financial Officer, Secretary, Treasurer and Director of various publicly traded companies within the retail, telecommunications, distribution, transportation, mortgage banking and construction sectors.

Pravin Borkar, CTO and Director (President, Safe-Pro USA), has over 30 years of experience in the engineering and manufacturing of ballistic protection systems for the U.S. Department of Defense. He has developed armor solutions for personnel and aircraft platforms including the CH-53 and Blackhawk.

Christopher Todd, President (Airborne Response), is a drone industry veteran and Certified Emergency Manager (CEM(R)) with more than 30 years of experience. He founded Airborne Response and is President of AUVSI Florida, with expertise in public safety drone deployment and emergency response.

For more information, visit the company’s website at https://safeprogroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SPAI are available in the company’s newsroom at https://ibn.fm/SPAI

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in Safe Pro Group Inc. SPAI | Leave a comment

MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Targets Multiple 2025–2026 Catalysts Across Rare Disease Pipeline

Posted on July 9, 2025 by MissionIR

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing therapies for rare diseases with unmet medical needs, issued a shareholder update outlining key clinical and strategic milestones. President and CEO Dr. Christopher J. Schaber highlighted upcoming data readouts for lead candidates, including Phase 3 FLASH 2 results for HyBryte(TM) (synthetic hypericin) in cutaneous T-cell lymphoma expected in 2H 2026, and multiple updates in 3Q and 4Q 2025 across psoriasis (SGX302) and Behçet’s Disease (SGX945). An investigator-initiated study also showed a 75% success rate at 18 weeks. The company projects HyBryte(TM) peak U.S. annual sales of over $90 million and global opportunities exceeding $2 billion across its pipeline. With approximately $7 million in cash and active exploration of partnerships and M&A, Soligenix aims to extend its cash runway into 1Q 2026 while preparing for global regulatory filings and potential commercialization.

To view the podcast, visit https://ibn.fm/NH5uN

About Soligenix Inc.

Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Its Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte(TM) (“SGX301” or synthetic hypericin) as a novel photodynamic therapy utilizing safe visible light for the treatment of cutaneous T-cell lymphoma (“CTCL”). With successful completion of the second Phase 3 study, regulatory approvals will be sought to support potential commercialization worldwide. Development programs in this business segment also include expansion of synthetic hypericin (“SGX302”) into psoriasis, the company’s first-in-class innate defense regulator (“IDR”) technology, dusquetide (“SGX942”) for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer, and (“SGX945”) in Behçet’s disease.

The company’s Public Health Solutions business segment includes development programs for RiVax(R), its ricin toxin vaccine candidate, as well as its vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax(TM), the company’s vaccine candidate for the prevention of COVID-19 (caused by SARS-CoV-2). The development of Soligenix’s vaccine programs incorporates the use of its proprietary heat stabilization platform technology, known as ThermoVax(R). To date, this business segment has been supported with government grants and contract funding from the National Institute of Allergy and Infectious Diseases (“NIAID”), the Defense Threat Reduction Agency (“DTRA”) and the Biomedical Advanced Research and Development Authority (“BARDA”).

For further information, visit the company’s website at www.Soligenix.com .

NOTE TO INVESTORS: The latest news and updates relating to SNGX are available in the company’s newsroom at https://ibn.fm/SNGX

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in Soligenix Inc. SNGX | Leave a comment

MissionIRNewsBreaks – Silvercorp Metals Inc.’s (NYSE American: SVM) (TSX: SVM) Growing Portfolio, Strong Balance Sheet Drive Investor Appeal

Posted on July 8, 2025 by MissionIR

Silvercorp Metals (NYSE American: SVM) (TSX: SVM), a Canadian mining company producing silver, gold, lead, and zinc, delivered its strongest fourth-quarter performance to date. The company closed out fiscal 2025, ended March, with significant growth in both revenue and operating cash flow with results reflecting increased production volumes and stronger realized prices across the company’s key metals. “Income from mine operations in the quarter climbed to $26.1 million, up from $13.0 million in Q4 Fiscal 2024. Silvercorp also increased capital investments in its core operations, spending $9.9 million in China and $3.1 million on its El Domo project in Ecuador during the quarter,” reads a recent article. “Even after these investments, the company added cash to its balance sheet and reported cash and short-term investments of $369.1 million, up from $354.6 million at the end of December 2024. It also held a $70.9 million portfolio of equity investments and has access to a $175 million stream financing credit to support El Domo mine construction.”

To view the full article, visit https://ibn.fm/btCSX

About Silvercorp Metals Inc.

Silvercorp is a Canadian mining company producing silver, gold, lead, and zinc with a long history of profitability and growth potential. The company’s strategy is to create shareholder value by 1) focusing on generating free cash flow from long life mines; 2) organic growth through extensive drilling for discovery; 3) ongoing merger and acquisition efforts to unlock value; and 4) long term commitment to responsible mining and ESG. For more information, visit the company’s website at www.SilverCorpMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to SVM are available in the company’s newsroom at https://ibn.fm/SVM

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in Silvercorp Metals Inc. SVM | Leave a comment

MissionIRNewsBreaks – Why HeartBeam Inc. (NASDAQ: BEAT) Is ‘One to Watch’

Posted on July 8, 2025 by MissionIR

HeartBeam (NASDAQ: BEAT) is a medical technology company developing a groundbreaking solution for at-home detection and monitoring of cardiac conditions. “HeartBeam’s vision is to redefine cardiac care by enabling early detection, proactive monitoring, and informed clinical decisions outside the confines of a traditional medical setting. Its patented approach not only delivers similar, but not identical, accuracy of conventional 12-lead ECGs for arrhythmia detection, but also unlocks future capabilities in ischemia detection, AI-assisted analysis, and longitudinal cardiac trend tracking,” reads a recent article. “As it approaches commercialization, HeartBeam is executing a multi-phase go-to-market strategy with initial U.S. rollout plans and a focus on high-margin, recurring revenue.”

To view the full article, visit https://ibn.fm/fcoOR

About HeartBeam Inc.

HeartBeam is a medical technology company dedicated to transforming cardiac care by providing powerful cardiac insights wherever the patient is. The company is creating the first-ever cable-free 12-lead ECG capable of capturing the heart’s electrical signals from three dimensions. This platform technology is designed to be used in portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care — all outside of a medical facility, thus redefining the future of cardiac health management. The company holds 13 U.S. and 4 international-issued patents related to technology enablement. For more information, visit www.HeartBeam.com.

NOTE TO INVESTORS: The latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in HeartBeam Inc. BEAT | Leave a comment

Safe Pro Group Inc. (NASDAQ: SPAI) Joins Russell Microcap(R) Index, Signaling Growing Investor Recognition, Market Visibility

Posted on July 8, 2025 by MissionIR
  • Safe Pro leverages patented AI and drone-based imagery analysis for threat detection and demining efforts.
  • Membership in the index reflects the company’s growing market presence and performance in AI-powered security and defense solutions, boosting visibility among institutional investors and fund managers.
  • The company’s flagship SpotlightAI(TM) platform has analyzed over 1.6 million real-world battlefield images from Ukraine, identifying more than 28,000 explosive threats.
  • Safe Pro is targeting a share of the global $15 billion defense technology market through its U.S.-made and HUBZone-certified offerings.

Safe Pro Group (NASDAQ: SPAI), an emerging provider of AI-powered security and threat detection solutions, announced its addition to the Russell Microcap(R) Index, effective after market close on June 27, 2025. The inclusion comes as part of FTSE Russell’s annual reconstitution, which ranks companies based on objective measures of market capitalization and style factors (https://ibn.fm/Bjka9).

For Safe Pro, joining the Russell Microcap(R) Index marks a new phase of investor awareness, offering automatic inclusion in funds and indexes tracked by institutional investors and fund managers. The inclusion further highlights the company’s growing market presence and performance and provides overall increased visibility within the investor community.

Founded to address global security, defense, and humanitarian challenges, Safe Pro has built a portfolio combining artificial intelligence, machine learning, and drone-based technologies. Its flagship SpotlightAI(TM) software platform supports real-time detection of over 150 types of mines and unexploded ordnance (“UXO”), built on a dataset of more than 1.6 million battlefield images from conflict zones such as Ukraine. The technology has identified over 28,000 threats so far, demonstrating practical results in one of the world’s most mine-contaminated regions.

The company’s growth is aligned with a larger industry trend, as defense and humanitarian organizations increasingly demand scalable, AI-enabled systems. SpotlightAI(TM) works by analyzing imagery from commercial, off-the-shelf drones, providing a rapid, efficient alternative to traditional human-based threat identification. Safe Pro’s cloud-based ecosystem, built on Amazon Web Services (“AWS”), supports high-volume data processing as well as enabling local real-time analysis through its OnSite software.

Beyond software, Safe Pro operates the Airborne Response division, which delivers mission-critical drone services for industries such as telecom, utilities, insurance, and public safety. Airborne Response specializes in drone-as-a-first-responder programs and infrastructure inspections, supporting operations with AI-enhanced data analysis.

In addition, Safe-Pro USA, another division, produces advanced, high performance ballistic protective systems, including body armor and plates for law enforcement as well as explosive ordnance disposal (“EOD”) suits and bomb blankets, all designed to meet or exceed NATO and U.S. military standards. Because all of its protective solutions are made in the United States and it is a HUBZone-certified small business, Safe-Pro USA is eligible for U.S. government procurement programs and public safety grants, positioning the company to expand its footprint across federal, state, and international markets.

The global landmine and UXO threat continues to affect nearly 60 countries, imposing social and economic burdens from agriculture to critical infrastructure. According to World Bank estimates, Ukraine alone faces roughly $30 billion in demining costs following contamination of more than 17 million hectares of land. As the “Breadbasket of Europe,” Ukraine’s agricultural sector has suffered more than $50 billion in losses since the beginning of the large-scale invasion (Source: All-Ukrainian Agrarian Council, July 2024). 

Through its portfolio of unique technologies, solutions and products, Safe Pro is well-placed to capture a portion of the estimated $15 billion global defense technology market, spanning AI-driven battlefield intelligence, drone services, and public safety applications.

Dan Erdberg, Safe Pro Group’s Chairman and CEO emphasized that the Russell Microcap(R) Index membership will support Safe Pro’s mission of advancing security technologies. “As AI and drone technologies rapidly transform the defense, security, and humanitarian sectors, our proprietary solutions are positioned to play a critical role,” he noted. “Being added to the Russell Microcap(R) Index marks a key milestone in expanding our reach with investors and highlights the broader relevance of our mission and technology. The inclusion into the FTSE Russell underscores our ongoing momentum and strategic growth.”

For more information, visit the company’s website at www.SafeProGroup.com.

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in Safe Pro Group Inc. SPAI | Leave a comment

MissionIRNewsBreaks – BluSky AI Inc. (OTC: BSAI) Secures 9.3 MW Power and Land for Flagship Utah Data Center

Posted on July 8, 2025 by MissionIR

BluSky AI (OTC: BSAI), a developer of modular AI data center infrastructure, announced the acquisition of its first operational site in Central, Utah, securing 9.3 MW of grid-connected power through an agreement with Digital Asset Management, LLC. In exchange for exclusive power rights, BluSky AI issued 20 million shares of restricted stock. The company also signed a ground lease with Wild Mustang Ventures LLC for 51.6 acres, with an option to purchase. These agreements position BluSky AI to launch and scale its flagship data center project with long-term power stability and operational control.

To view the full press release, visit https://ibn.fm/9hLv9

About BluSky AI Inc.

BluSky AI, headquartered in Salt Lake City, Utah, is a modular data center company dedicated to providing innovative and sustainable infrastructure solutions that power the AI revolution. BluSky AI plans to revolutionize the AI compute landscape by addressing the immediate global AI supply shortage with cutting-edge, turnkey modular solutions across multiple locations. BluSky plans to transform the way AI companies access the compute power needed to drive innovation and growth.

For more information, visit the company’s website at www.BluSkyAIDataCenters.com

NOTE TO INVESTORS: The latest news and updates relating to BSAI are available in the company’s newsroom at http://ibn.fm/BSAI

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in BlueSky AI Inc. BSAI | Leave a comment

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic

Posted on July 8, 2025 by MissionIR
  • The acquisition of Cohen and Associates, a respected interventional psychiatry practice, by NRx subsidiary HOPE Therapeutics, is expected to be immediately accretive to revenue and EBITDA.
  • Cohen, serving the Sarasota-Bradenton area in Florida, specializes in treatments, including ketamine and TMS, for mood disorders, PTSD, and suicidal depression.
  • HOPE Therapeutics is expanding toward a target of 30 clinics with a $100 million run rate by the end of 2025.

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its wholly-owned subsidiary HOPE Therapeutics, Inc., a multi-site clinical care delivery organization, recently signed a binding letter of intent to acquire a 49% stake in Cohen and Associates, LLC, a respected neuropsychiatry clinic based in western Florida (https://ibn.fm/geIxF).

The agreement, announced on June 26, positions Cohen as a foundational clinic in the Sarasota-Bradenton region for HOPE’s growing network. Cohen and Associates, led by Dr. Rebecca Cohen, offers a comprehensive range of psychiatric care options, including ketamine infusions, Spravato, transcranial magnetic stimulation (“TMS”), and medication management for conditions such as suicidal depression and PTSD.

Founded in 2014, Cohen has established a reputation for delivering thorough psychiatric evaluations and interventional care. Dr. Cohen, an interventional psychiatrist and psychopharmacologist, is known nationally for her expertise in TMS. Her academic achievements include recognition from Tufts University, Boston University, and Georgetown University, and she has been honored as a Fellow of both the American Psychiatric Association and the International Clinical TMS Society.

“I am thrilled to be working with HOPE at this exciting juncture in the company’s evolution,” Dr. Cohen said. “Our goal will always be to deliver outstanding patient care by offering the best available treatments and individualized care.”

HOPE Therapeutics is building a network of interventional psychiatry clinics that combine advanced treatments such as TMS and ketamine with a digital therapeutic-enabled platform to improve outcomes. The company is targeting up to 30 clinics and a $100 million pro forma run rate by the end of 2025.

HOPE’s co-CEOs, Jonathan Javitt and Matthew Duffy, expressed confidence that the Cohen acquisition will support their mission of expanding evidence-based, compassionate care. “We are delighted to welcome Rebecca and her team to the HOPE family. Her extensive experience with neuroplastic therapies, combined with compassionate patient care exemplify our culture of bringing HOPE to life,” they said.

According to the announcement, the transaction is expected to be immediately accretive to both revenue and EBITDA, underlining its strategic fit for HOPE Therapeutics’ clinic-based growth plans. The acquisition is subject to final agreements and standard closing conditions, with further details to be disclosed once definitive transaction documents are signed.

NRx Pharmaceuticals has been active on multiple clinical development fronts, working to advance therapies for mood disorders, PTSD, and acute suicidality through its NMDA-based platform. The company recently filed a new application for a Commissioner’s National Priority Voucher to accelerate review of NRX-100, a preservative-free intravenous ketamine formulation. In parallel, the company has filed an Abbreviated New Drug Application (“ANDA”) for NRX-100 with a request for priority review.

For more information, visit the company’s website at www.NRxPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to NRXP are available in the company’s newsroom at https://ibn.fm/NRXP

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in NRx Pharmaceuticals Inc. NRXP | Leave a comment

New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Positioned to Supply Critical Global Silver Demand from Bolivia Assets

Posted on July 7, 2025 by MissionIR
  • New Pacific Metals owns two of the largest undeveloped open-pit silver projects globally, both located in Bolivia.
  • Its flagship Silver Sand project is projected to produce 12 million ounces of silver annually at low all-in sustaining costs.
  • The Carangas project could add 6.6 million ounces of silver annually, with over 1 million ounces of gold potential at depth.
  • New Pacific is working through Bolivia’s permitting process to unlock the upside potential of its high-quality, large-scale projects.
  • Global silver demand, particularly for industrial and renewable energy applications, adds urgency to project development.

New Pacific Metals (NYSE American: NEWP) (TSX: NUAG), a Canadian exploration and development company, is in a unique position to fill a critical and growing supply gap in the global silver market, with two large-scale projects in Bolivia. The company’s progress is focused on advancing these assets through permitting in a country that remains geologically rich.

The company’s two primary projects, Silver Sand and Carangas, are among the best undeveloped open-pit silver assets in the world. A preliminary feasibility study (“PFS”) published in June 2024 highlights the strong potential of the flagship Silver Sand project, which is expected to deliver 12 million ounces of silver annually over a 13-year mine life. The early years are even more productive, with output estimated at 15 million ounces per year, with total projected production reaching 157 million ounces. The project carries a post-tax net present value (“NPV5%”) of US$740 million and a 37% internal rate of return (“IRR”) at a conservative silver price of US$24 per ounce. The all-in sustaining cost is estimated at just US$10.69 per ounce, with a rapid payback period of under two years.

The Carangas Project’s preliminary economic assessment (“PEA”), released in September 2024, outlines a low-cost open-pit mine that targets only the upper silver-lead-zinc zone to produce 6.6 million ounces of silver annually over a 16-year mine life. The economics are also favorable: a post-tax NPV5% of US$501 million, a 26% IRR, AISC of $7.60 per ounce net of lead and zinc by-products, and a 3.2-year payback period at $24 per ounce silver. Notably, Carangas also has more than 1 million ounces of gold potential at depth, not yet incorporated into the PEA.

Together, these projects position New Pacific to potentially produce nearly 19 million ounces of silver per year, placing it in the upper ranks of primary silver producers, once both projects enter production.

Permitting efforts for the two projects are well underway, though the process requires time and patience. Still, it highlights a major opportunity: Bolivia is starved of foreign investment needed to revitalize its mining sector—offering significant upside for early movers.

New Pacific is backed by strong players in the precious metals market. The company is 28% owned by Silvercorp Metals (NYSE-A: SVM) (TSX: SVM), a Canadian mining company producing silver with a long history of profitability, and 13% owned by Pan American Silver (NYSE: PAAS) (TSX: PAAS), which bills itself as the world’s premier silver producer. Both shareholders view the Bolivian projects as serious long-term strategic opportunities that could also attract buyers or partners once development milestones are reached.

Global demand for silver is rising—not just from investors, but from industrial and renewable energy sectors, including photovoltaic solar panels and electric vehicles. According to the World Silver Survey, industrial applications now account for an astonishing 83% of annual silver demand (https://ibn.fm/pniUI).

With few large-scale silver projects under development worldwide, New Pacific’s pipeline is notable. As many silver producers pivot to gold or base metals simply because of a lack of primary silver resources, New Pacific offers pure silver leverage—a rare commodity in today’s market.

For more information, visit the company’s website at www.newpacificmetals.com/welcome.

NOTE TO INVESTORS: The latest news and updates relating to NEWP are available in the company’s newsroom at https://ibn.fm/NEWP 

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in New Pacific Metals Corp. NEWP | Leave a comment

Clene Inc. (NASDAQ: CLNN) to Conduct Neurofilament Biomarker Analysis for CNM-Au8(R) in ALS in Early Q4 2025

Posted on July 7, 2025 by MissionIR
  • The FDA offered supportive feedback on Clene’s proposed statistical analysis plan during a recent Type C meeting.
  • The neurofilament biomarker analysis results could support an accelerated approval submission for CNM-Au8 later in 2025.
  • Clene has two additional FDA meetings scheduled in Q3 2025 to discuss ALS survival data and its MS program.
  • Nearly 200 ALS patients are participating in the NIH-sponsored Expanded Access Program for CNM-Au8.
  • The analysis aims to validate the neuroprotective effects shown in previous HEALEY Platform Trial results.

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), is set to move ahead with neurofilament biomarker analyses for its lead candidate CNM-Au8(R) ALS early in the fourth quarter of 2025. The announcement follows a recent productive Type C meeting with the U.S. Food and Drug Administration (“FDA”) (https://ibn.fm/F5AHk). 

The planned analyses will examine changes in neurofilament light chain (“NfL”), a recognized biomarker for neurodegeneration, among nearly 200 ALS patients treated through the National Institutes of Health–sponsored Expanded Access Program (“EAP”) for CNM-Au8. The company’s statistical plan will compare these patients to matched ALS controls, with a primary analysis at nine months and a supportive analysis at six months of treatment.

In the Expanded Access Program, CNM-Au8 is being administered on a compassionate use basis to people living with ALS. The company will analyze whether reductions in NfL from this cohort mirror or exceed the neuroprotective trends reported in the double-blind HEALEY trial.

Benjamin Greenberg, MD, Head of Medical at Clene, described the FDA’s feedback as “constructive” and said the agency’s acceptance of Clene’s revised statistical plan is expected this summer. Clene has already resubmitted its updated analysis plan to the FDA to incorporate requested changes, aiming to finalize the evaluation framework ahead of its fourth-quarter biomarker review.

“We are encouraged by the FDA’s collaborative approach and their constructive feedback on our NfL biomarker analysis plan from the ongoing NIH-sponsored EAP program,” said Greenberg. “With two additional FDA meetings scheduled to discuss long-term ALS survival results and the End-of-Phase 2 MS results, we are advancing our ALS and MS programs to deliver an innovative therapy for people living with neurodegenerative diseases.”

A positive outcome from this NfL assessment is likely to strengthen Clene’s case for a new drug application (“NDA”) submission under the accelerated approval pathway before the end of 2025. The company is seeking to build on data from the HEALEY ALS Platform Trial, where CNM-Au8 showed encouraging neuroprotective signals over a six-month period.

Alongside the biomarker study, Clene confirmed two additional FDA meetings are scheduled for the third quarter of 2025. The first will review survival data from patients receiving 30 mg CNM-Au8 compared with controls from another arm of the HEALEY Platform Trial. The second meeting will focus on the company’s multiple sclerosis program, discussing Phase 2 data from the VISIONARY-MS trial and Clene’s plans for a Phase 3 study targeting cognitive outcomes.

The FDA’s engagement on multiple fronts highlights a potentially promising path forward for CNM-Au8, an oral suspension of gold nanocrystals designed to improve cellular energy production and utilization, which is critical for maintaining neuronal health. Clene hopes these data will support broader approval opportunities for ALS, where treatment options remain limited.

In addition to its ALS program, Clene is keeping momentum in its multiple sclerosis research, using similar bioenergetic principles focused on mitochondria within the central nervous system to develop therapies that could improve cognitive outcomes for people living with MS. The company expects its end-of-Phase 2 MS discussion with the FDA in the third quarter will set the stage for a larger Phase 3 trial.

For more information, visit the company’s website at www.Clene.com.

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in Clene Inc. CLNN | Leave a comment

MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Set to Revolutionize REE Separation with RapidSX(TM)

Posted on July 3, 2025 by MissionIR

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a critical metals technology company developing scalable rare earth element (“REE”) refining infrastructure in North America, marked a significant milestone in the development of a domestic REE supply chain. Ucore was featured in a recent article that discussed the groundbreaking of its Louisiana Strategic Metals Complex (“SMC”) in Alexandria. “This facility represents the company’s first commercial REE refining operation and is poised to play a pivotal role in reducing North America’s reliance on foreign sources for critical minerals… The Louisiana SMC is designed to utilize Ucore’s proprietary RapidSX(TM) technology, an advanced solvent extraction process that offers a more efficient and environmentally friendly method for separating REEs… The U.S. Department of Defense (‘DoD’) has recognized the strategic importance of the Louisiana SMC by providing $18.4 million in funding to accelerate the installation of the RapidSX technology at the facility. This investment underscores the DoD’s commitment to strengthening the domestic supply chain for critical minerals essential to national security and technological advancement.”

To view the full article, visit https://ibn.fm/7lapS

About Ucore Rare Metals Inc.

Ucore is focused on rare- and critical-metal resources, extraction, beneficiation and separation technologies with the potential for production, growth and scalability. Ucore’s vision and plan is to become a leading advanced technology company, providing best-in-class metal separation products and services to the mining and mineral extraction industry. Through strategic partnerships, this plan includes disrupting the People’s Republic of China’s control of the North American REE supply chain through the near-term development of a heavy and light rare-earth processing facility in the U.S. state of Louisiana, subsequent SMCs in Canada and Alaska and the longer-term development of Ucore’s 100% controlled Bokan-Dotson Ridge Rare Heavy REE Project on Prince of Wales Island in Southeast Alaska, USA. For more information, visit the company’s website at www.Ucore.com.

NOTE TO INVESTORS: The latest news and updates relating to UURAF are available in the company’s newsroom at https://ibn.fm/UURAF

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
[email protected]

MissionIR is powered by IBN

Posted in Ucore Rare Metals Inc. UURAF | Leave a comment